PROTEOSTASIS THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PTI and Encourages Investors to Contact the Firm
NEW YORK, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Proteostasis Therapeutics, Inc. (NASDAQ: PTI) (“PTI”) breached …